P
Prime Medicine, Inc. (PRME)
NGM – Real vaqt narxi. Valyuta: USD
3.43
+0.25 (7.86%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.43
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 7:05 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
3.43
+0.25 (7.86%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.43
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 7:05 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $114.5M naqd pul zahiralaridan ($64.1M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $137.9M jami joriy majburiyatlardan $36.3M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (1.5) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$42.9M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 3.80 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 3.80 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 1.49 | 0.30 | 5.0 | |
| Qarz/Aktivlar nisbati | 0.39 | 1.04 | 6.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 6.4 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | N/A | 3M | 5M | 4M |
| Yalpi foyda | -12M | -5M | -3M | -3M | -3M |
| Operatsion daromad | -117M | -191M | -202M | -208M | -207M |
| Sof foyda | -122M | -198M | -196M | -201M | -198M |
| EBITDA | -105M | -187M | -196M | -201M | -199M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 112.23 | 37.5 | 10 |
| Keyingi chorak | 524.2 | 27.07 | 10 |
| Joriy yil | 176.99 | 25.99 | 10 |
| Keyingi yil | 75.49 | 9.17 | 8.0 |
| O‘rtacha ball | 9.5 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 2.15 | -6.59 | -27.26 | -14.31 | 1.5 |
| Yil/Yil | -41.12 | 5.33 | 30 | 16.29 | 6.3 |
| 3 yil o‘rtacha | 684.43 | -21.38 | 30.15 | -6.93 | 5.5 |
| 5 yil o‘rtacha | 590.46 | -957.45 | 30.15 | -165.2 | 5.5 |
| O‘rtacha ball | 4.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |